These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21099717)

  • 1. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.
    Miwa T; Hirose Y; Sasaki H; Ezaki T; Yoshida K; Kawase T
    Neurosurgery; 2011 Jan; 68(1):206-12. PubMed ID: 21099717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
    Li MY; Wang YY; Cai JQ; Zhang CB; Wang KY; Cheng W; Liu YW; Zhang W; Jiang T
    PLoS One; 2015; 10(6):e0130872. PubMed ID: 26115094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The genome atlas of brain tumors].
    Natsume A; Motomura K; Wakabayashi T
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():473-80. PubMed ID: 20979298
    [No Abstract]   [Full Text] [Related]  

  • 4. IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.
    Jha P; Suri V; Sharma V; Singh G; Sharma MC; Pathak P; Chosdol K; Jha P; Suri A; Mahapatra AK; Kale SS; Sarkar C
    Exp Mol Pathol; 2011 Aug; 91(1):385-93. PubMed ID: 21569770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
    Sanson M; Marie Y; Paris S; Idbaih A; Laffaire J; Ducray F; El Hallani S; Boisselier B; Mokhtari K; Hoang-Xuan K; Delattre JY
    J Clin Oncol; 2009 Sep; 27(25):4150-4. PubMed ID: 19636000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity analysis in malignant gliomas.
    Mizoguchi M; Kuga D; Guan Y; Hata N; Nakamizo A; Yoshimoto K; Sasaki T
    Brain Tumor Pathol; 2011 Jul; 28(3):191-6. PubMed ID: 21629980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
    Chamberlain MC
    Neurology; 2014 Jun; 82(23):2147-8. PubMed ID: 24912510
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcriptional expression of glioma chemotherapy drugs associated marker molecules in gliomas and normal brain tissues.
    Zhao Y; Xue Y; Zhang Q; Wang K; Yin J; Lou M
    Cancer Biomark; 2013; 13(1):59-66. PubMed ID: 23736022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the application of molecular biomarkers in gliomas.
    Wang J; Su HK; Zhao HF; Chen ZP; To SS
    Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
    Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in prognostic markers for gliomas.
    Aquilanti E; Miller J; Santagata S; Cahill DP; Brastianos PK
    Neuro Oncol; 2018 Nov; 20(suppl_7):vii17-vii26. PubMed ID: 30412261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.
    Horbinski C; McCortney K; Stupp R
    Neuro Oncol; 2021 May; 23(5):858-860. PubMed ID: 33830235
    [No Abstract]   [Full Text] [Related]  

  • 15. Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.
    Schittenhelm J; Mittelbronn M; Meyermann R; Melms A; Tatagiba M; Capper D
    Acta Neuropathol; 2011 Nov; 122(5):651-2. PubMed ID: 21983902
    [No Abstract]   [Full Text] [Related]  

  • 16. Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
    Wick W; Winkler F
    Cancer; 2018 Jul; 124(13):2674-2676. PubMed ID: 29698549
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
    Kros JM; Huizer K; Hernández-Laín A; Marucci G; Michotte A; Pollo B; Rushing EJ; Ribalta T; French P; Jaminé D; Bekka N; Lacombe D; van den Bent MJ; Gorlia T
    J Clin Oncol; 2015 Jun; 33(17):1943-50. PubMed ID: 25918297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.
    Joo M; Park SH; Chang SH; Kim H; Choi CY; Lee CH; Lee BH; Hwang YJ
    Hum Pathol; 2013 Feb; 44(2):282-8. PubMed ID: 23058249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.
    Hayashi S; Kitamura Y; Hirose Y; Yoshida K; Sasaki H
    J Neurooncol; 2017 Mar; 132(1):119-126. PubMed ID: 28025770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas.
    Filipski K; Braun Y; Zinke J; Roller B; Baumgarten P; Wagner M; Senft C; Zeiner PS; Ronellenfitsch MW; Steinbach JP; Plate KH; Gasparoni G; Mittelbronn M; Capper D; Harter PN
    Acta Neuropathol; 2019 Aug; 138(2):331-334. PubMed ID: 31065834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.